Novo Nordisk’s Wegovy debuts in India: How it works, who it’s for, and how much it costs

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly’s Mounjaro. Available by June 2025, Wegovy is a once-weekly injectable using a user-friendly FlexTouch pen. Targeting India’s large obese population, Novo Nordisk aims to capture a significant share of the ₹576 crore anti-obesity market.